ACHV SCHEDULE 13G/A: SEC filing
Filed with the SEC on · accession 0001738048-26-000088
ACHV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Venrock Healthcare Capital Partners entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of 5,502,064 shares, or 5.2%, of Achieve Life Sciences common stock as of September 30, 2026.
Summary of the filing
Venrock Healthcare Capital Partners entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of 5,502,064 shares, or 5.2%, of Achieve Life Sciences common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.
Key details
✦ Ask GOAX AI about this filing — what it means for ACHV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ACHV?
Click hereFrequently asked questions
What did ACHV file with the SEC on Nov 16, 2026?
ACHV filed a SCHEDULE 13G/A (SEC filing). Venrock Healthcare Capital Partners entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of 5,502,064 shares, or 5.2%, of Achieve Life Sciences common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other ACHV SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 8-K · SEC filingNov 10, 2026
- 10-Q · SEC filingNov 10, 2026
- 8-K · Cfo changeOct 1, 2026
- SCHEDULE 13G · SEC filingAug 17, 2026
- 424B5 · Secondary offeringAug 14, 2026
- 8-K · Secondary offeringAug 14, 2026
- SCHEDULE 13G · SEC filingAug 13, 2026
Get alerts when ACHV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days